Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
drugs
2
×
life sciences
bioinnovation capital
biolabs
boston
boston blog main
chemotherapy
daraprim
diagnostics
drug pricing
epipen
epipens
exome
gene therapy
generic drugs
hatteras venture partners
healthit
insulin
investing
johannes fruehauf
labcentral
life science
martin shkreli
medical devices
mylan
national blog main
national xcon
novartis
oncology
peter kolchinsky
price collusion
raleigh-durham
raleigh-durham blog main
raleigh-durham top stories
spinal muscular atrophy
the biotech social contract
turin pharmaceuticals
vc
venture capital
What
life
2
×
sciences
2
×
biotech
cash
committed
deploy
driving
drug
far
fund
good
hatteras
healthcare
history
improved
industry
innovation
innovations
investment
investments
kicking
latest
launches
long
medical
million
new
outcomes
partners
plans
pricing
proud
public
science
startups
venture
wide
Language
unset
Current search:
xconomy.com
×
sciences
×
life
×
drugs
×
biotech
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
